Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree
Authors:
- Chunyang KangCKChunyang Kang
- Jiajun ChenJCJiajun Chen
- Lei ZhangLZLei Zhang
Open Access
- 25 June 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (25) , e26443
Abstract
Rationale: Autosomal dominant hypocalcaemia type 1 (ADH1) is a genetic disease characterized by benign hypocalcemia, inappropriately low parathyroid hormone levels and mostly hypercalciuria. It is caused by the activating mutations of the calcium-sensing receptor gene (CASR), which produces a left-shift in the set point for extracellular calcium. Patient concerns: A 50-year-old man presenting with muscle spasms was admitted into the hospital. He has a positive familial history for hypocalcemia. Auxiliary examinations demonstrated hypocalcemia, hyperphosphatemia, normal parathyroid hormone level and nephrolithiasis. A missense heterozygous variant in CASR, c 613C > T (p. Arg205Cys) which has been reported in a familial hypocalciuric hypercalcemia type 1 patient was found in the patient's genotype. It is the first time that this variant is found associating with ADH1. The variant is predicted vicious by softwares and cosegregates with ADH1 in this pedigree. CASR Arg205Cys was deduced to be the genetic cause of ADH1 in the family. Diagnosis: The patient was diagnosed with ADH1 clinically and genetically. Interventions: Oral calcitriol, calcium and hydrochlorothiazide were prescribed to the patient. Outcomes: After the treatments for 1 week, the patient's symptom was improved and the re-examination revealed serum calcium in the normal range. A 3-month follow-up showed his symptom was mostly relieved. Lessons: The variant of CASR Arg205Cys, responsible for ADH1 in this family, broadened the genetic spectrum of ADH1. Further and more studies are required to evaluate the correlation between genotype and phenotype in ADH1 patients.Keywords
Funding Information
- Department of Science and Technology of Jilin Province (20180414049GH)
- Department of Science and Technology of Jilin Province (20200404133YY)
- Norman Bethune Program of Jilin University (2015216)
- Jilin Provincial Special Program for Health Research Talents (20200316)
This publication has 17 references indexed in Scilit:
- Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sitesHuman Molecular Genetics, 2012
- Identification of rare and frequent variants of the CASR gene by high-resolution meltingClinica Chimica Acta, 2012
- Claudin‐14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathwayThe EMBO Journal, 2012
- Clinical Vignette: PTH(1–34) Replacement Therapy in a Child With Hypoparathyroidism Caused by a Sporadic Calcium Receptor MutationJournal of Bone and Mineral Research, 2009
- Structure and function of the human calcium‐sensing receptor: insights from natural and engineered mutations and allosteric modulatorsJournal of Cellular and Molecular Medicine, 2007
- Diseases associated with the extracellular calcium-sensing receptorCell Calcium, 2004
- The Extracellular Calcium-sensing Receptor Dimerizes through Multiple Types of Intermolecular InteractionsJournal of Biological Chemistry, 2001
- A Familial Syndrome of Hypocalcemia with Hypercalciuria Due to Mutations in the Calcium-Sensing ReceptorNew England Journal of Medicine, 1996
- Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutationNature Genetics, 1994
- FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END‐ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCYClinical Endocrinology, 1976